Concepedia

Concept

spondyloarthritis

Parents

Children

4.1K

Publications

196.3K

Citations

15.1K

Authors

3.2K

Institutions

HL-A27 Immunogenetic Linkage Era

1970 - 1976

The 1970–1976 period crystallized a genetic-immunogenetic paradigm in spondyloarthropathies, foregrounding Human Leukocyte Antigen 27 (HL-A27) as a shared susceptibility marker across ankylosing spondylitis, Reiter's syndrome, and related enthesopathies. Research emphasized enthesopathy and sacroiliac inflammatory lesions as core features, linking inflammatory bowel disease and other gastrointestinal manifestations within a unified disease spectrum and highlighting familial clustering as evidence of heritable risk. Population-level investigations began to use carrier status to refine prevalence estimates and risk stratification, laying groundwork for genetic screening approaches.

Genetic and immunogenetic studies converge on HL-A27 as a pivotal marker linking ankylosing spondylitis and Reiter's syndrome, with multiple papers showing high W27 frequencies in affected individuals and familial patterns suggesting shared pathogenic pathways [1], [2], [17], [16], [W201? not present], [6].

Enthesopathy and sacroiliac/inflammatory entheseal changes emerge as core pathology across spondyloarthritides, with pathology papers detailing enthesopathy and destructive vertebral lesions that frame AS and related conditions as unified diseases [3], [5], [18], [14].

Gastrointestinal comorbidity appears linked with spondyloarthritides, with studies showing inflammatory bowel disease in AS and musculo-skeletal complications of Crohn’s disease, highlighting a systemic inflammatory spectrum [4], [10].

Familial clustering and inheritance signals arise, including families with AS, Reiter's disease, and RA, and inheritance studies connecting HL-A27 status to disease occurrence, suggesting heritable risk factors [6], [17], [20].

Epidemiologic implications of HL-A27 show how carrier status stratifies risk and guides population-level prevalence estimates, with healthy W27 individuals experiencing higher AS prevalence in some cohorts [13], [8], [7].

HLA-B27 Immunogenetics

1977 - 1983

HLA-B27 Immune Crosstalk

1984 - 1994

Genetics-Driven Standardization in Spondyloarthritis

1995 - 2001

TNF Blockade Paradigm

2002 - 2008

Spondyloarthritis Genetic-Immunologic Imaging Paradigm

2009 - 2015

Targeted Biologic Axial Spondyloarthritis

2016 - 2022